Wolfgang Zierhut

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

Pascal Vranckx, Marco Valgimigli, Lars Eckardt et al. · The Lancet · 2019 · 659 citations

Medicine, Cardiology, Pharmacology +16

Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy.

Wolfgang Zierhut, Heinz‐Gerd Zimmer · Circulation Research · 1989 · 181 citations · Full text

Medicine, Pharmacology, Physiology +17

The Cardiac Fas (APO-1/CD95) Receptor/Fas Ligand System

Kai C. Wollert, Jörg Heineke, Jürgen Westermann et al. · Circulation · 2000 · 107 citations

Life Sciences, Cardiology, Cell Biology +13

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial

Pascal Vranckx, Thorsten Lewalter, Marco Valgimigli et al. · American Heart Journal · 2017 · 86 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats.

Wolfgang Zierhut, Heinz‐Gerd Zimmer, Anne‐Marie Gerdes · Circulation Research · 1991 · 79 citations

Medicine, Pharmacology, Physiology +13